Concomitant amifostine during radiotherapy reduces the cytogenetic damage in head and neck cancer patients

Research output: Contribution to journalArticleResearchpeer-review

Original languageEnglish
Pages (from-to)179-180A
JournalChromosome Research
Volume15
Issue number1
Publication statusPublished - 1 Jan 2007

Cite this